Download
https://www.ndtvprofit.com/business/gilead-said-to-near-immunomedics-bid-worth-more-than-20-billion?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
The deal, proposed at $88 per share, values Immunomedics at more than twice its closing price on Friday.
Share